68-5
22/120

oxidative modification of tryptophan and tyrosine resi-dues. Biochemistry, 2007; 46: 4898-4911. 15) Napolitano MJ, Green BJ, Nicoson JS, Margerum DW: Chlorine dioxide oxidations of tyrosine, N-acetyltyro-sine, and dopa. Chem Res Toxicol, 2005; 18: 501-508. 16) Stewart DJ, Napolitano MJ, Bakhmutova-Albert EV, Margerum DW: Kinetics and mechanisms of chlorine dioxide oxidation of tryptophan. Inorg Chem, 2008; 47: 1639-1647.17) Ogata N, Miura T: Inhibited the binding of spike protein of SARS-Cov-2 to human angiotensin-con-verting enzyme 2 by chlorine dioxide. Annals of Phar-macology and Pharmaceutics, 2020; 5: 1195. 18) Akamatsu A, Lee C, Morino H, Miura T, Ogata N, Shibata T: Six-month low level chlorine dioxide gas inhalation toxicity study with two-week recovery period in rats. J Occup Med Toxicol, 2012; 7: 2.19) Ogata N, Shibata T: Protective effect of low-concentra-tion chlorine dioxide gas against influenza A virus infection. J Gen Virol, 2008; 89: 60-67. 20) Ogata N, Sakasegawa M, Miura T, et al: Inactivation of airborne bacteria and viruses using extremely low concentrations of chlorine dioxide gas. Pharmacology, 2016; 97: 301-306. 21) Ogata N: Inactivation of influenza virus haemagglu-tinin by chlorine dioxide: oxidation of the conserved tryptophan 153 residue in the receptor-binding site. J Gen Virol, 2012; 93: 2558-2563. 22) U.S. Department of Labor’s Occupational Safety and Health Administration: Occupational safety and health guideline for chlorine dioxide. 2006. https://www.osha.gov/chemicaldata/16. Accessed 5 Nov 2021. 23) Dalhamn T: Chlorine dioxide toxicity in animal exper-iments and industrial risks. AMA Arch Ind Health, 1957; 15: 101-10724) McDevitt JJ, Rudnick SN, Radonovich LJ: Aerosol susceptibility of influenza virus to UV-C light. Appl Environ Microbiol, 2012; 78: 1666-1669.25) Darnell MER, Subbarao K, Feinstone SM, et al: Inacti-472vation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods, 2004; 121: 85-91.26) Michael R: Development and repair of cataract induced by ultraviolet radiation. Othhalmic Res, 2000; 32 Supple 1: 1-45.27) Narayanan DL, Saladi RN, Fox JL: Ultraviolet radiation and skin cancer. Int J Dermatol, 2010; 49: 978-986. 28) Cho M, Chung H, Choi W, Yoon J: Different inactiva-tion behaviors of MS-2 phage and Escherichia coli in TiO2 photocatalytic disinfection. Appl Environ Micro-biol, 2005; 71: 270-275. 29) Hakim H, Thammakarn C, Suguro A, et al: Evaluation of sprayed hypochlorous acid solutions for their viru-cidal activity against avian influenza virus through in vitro experiments. J Vet Med Sci, 2015; 77: 211-215. 30) Hakim H, Thammakarn C, Suguro A, et al: Aerosol disinfection capacity of slightly acidic hypochlorous acid water towards Newcastle disease virus in the air: an in vitro experiment. Avian Dis, 2015; 59: 486-491. 31) Hulkower RL, Casanova LM, Rutala WA, Weber DJ, Sobsey MD: Inactivation of surrogate coronaviruses on hard surfaces by health care germicides. Am J Infect Control, 2011; 39: 401-407. 32) Cutts TA, Robertson C, Theriault SS, et al: Efficacy of microbicides for inactivation of Ebola-Makona virus on a non-porous surface: a targeted hygiene interven-tion for reducing virus spread. Sci Rep, 2020; 10: 15247.33) U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC): Guidelines for environmental infection control in health-care facil-ities. 2003; 1-241. https://www.cdc.gov/infectioncon-trol/guidelines/environmental/index.html. Accessed 5 Nov 2021.34) Ogata N, Shibata T: Disinfection of virus in room air. World J Pharm Res, 2022; 11: 76-90.35) Obinata K: Examination of preventive effect and safety of chlorine dioxide on nosocomial pneumonia. Impact, 2021; 3: 37-39.

元のページ  ../index.html#22

このブックを見る